Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Operating Expenses: 2010-2025

Historic Operating Expenses for Niagen Bioscience (NAGE) over the last 14 years, with Sep 2025 value amounting to $17.7 million.

  • Niagen Bioscience's Operating Expenses rose 20.86% to $17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.4 million, marking a year-over-year increase of 8.05%. This contributed to the annual value of $53.9 million for FY2024, which is 4.47% down from last year.
  • As of Q3 2025, Niagen Bioscience's Operating Expenses stood at $17.7 million, which was up 3.82% from $17.0 million recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Operating Expenses registered a high of $19.4 million during Q3 2021, and its lowest value of $11.1 million during Q4 2024.
  • Its 3-year average for Operating Expenses is $14.5 million, with a median of $14.6 million in 2025.
  • Per our database at Business Quant, Niagen Bioscience's Operating Expenses soared by 53.51% in 2021 and then slumped by 31.65% in 2022.
  • Over the past 5 years, Niagen Bioscience's Operating Expenses (Quarterly) stood at $16.2 million in 2021, then dropped by 16.83% to $13.5 million in 2022, then dropped by 2.64% to $13.1 million in 2023, then decreased by 15.41% to $11.1 million in 2024, then climbed by 20.86% to $17.7 million in 2025.
  • Its Operating Expenses stands at $17.7 million for Q3 2025, versus $17.0 million for Q2 2025 and $14.6 million for Q1 2025.